SIO GENE THERAPIES

Sio Gene Therapies, formerly known as Axovant, is a clinical-stage company with a singular focus on pushing the boundaries of gene therapy to develop treatments for debilitating neurodegenerative diseases, including GM1 gangliosidosis, Tay-Sachs/Sandhoff disease, and Parkinson’s disease. Sio is leveraging its foundational scientific expertise built on decades of research, extensive collaborations with leading gene therapy institutes, and a flexible vector platform to liberate patients with debilitating diseases through the transformational power of gene therapies.

#SimilarOrganizations #People #Financial #Website #More

SIO GENE THERAPIES

Social Links:

Facebook

Linkedin

Twitter

Industry:

Biopharma Biotechnology Neuroscience Therapeutics

Founded:

2014-01-01

Address:

New York, New York, United States

Country:

United States

Website Url:

http://www.siogtx.com

Total Employee:

101+

Status:

Active

Contact:

833-296-8268

Email Addresses:

[email protected]

Total Funding:

129.7 M USD

Technology used in webpage:

SPF Microsoft Exchange Online Amazon Office 365 Mail IPv6 Amazon Route 53 Pound Sterling Typekit Microsoft New Relic

Similar Organizations

alpha-omega-logo

Alpha Omega

Defining Neuroscience Technology

avalo-therapeutics-logo

Avalo Therapeutics

Avalo Therapeutics is a clinical-stage biopharmaceutical company.

context-therapeutics-logo

Context Therapeutics

Context Therapeutics is a clinical-stage biopharmaceutical company.

corvus-pharmaceuticals-logo

Corvus Pharmaceuticals

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.

leap-therapeutics-logo

Leap Therapeutics

Leap Therapeutics is a clinical-stage biopharmaceutical company.

minerva-neuroscience-logo

Minerva Neuroscience

Minerva Neurosciences is a clinical-stage biopharmaceutical company

sab-biotherapeutics-logo

SAB Biotherapeutics

SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.

sellas-life-sciences-logo

SELLAS Life Sciences

SELLAS Life Sciences is a late-stage biopharmaceutical company.

tarsus-pharmaceuticals-logo

Tarsus Pharmaceuticals

Tarsus Pharmaceuticals is a clinical-stage biopharmaceutical company.

urogen-pharma-logo

UroGen Pharma

UroGen Pharma is a clinical-stage biopharmaceutical company.

vyriad-logo

Vyriad

Vyriad is a clinical stage biopharmaceutical company.

Current Advisors List

lawrence-olanoff_image

Lawrence Olanoff Member of the Board of Directors @ Sio Gene Therapies
Board_member

vivek-ramaswamy_image

Vivek Ramaswamy Board Of Directors @ Sio Gene Therapies
Board_member
2014-01-01

Current Employees Featured

j-fraser-wright_image

J. Fraser Wright
J. Fraser Wright Chief Technology Officer @ Sio Gene Therapies
Chief Technology Officer

ilise-lombardo_image

Ilise Lombardo
Ilise Lombardo Chief Medical Officer @ Sio Gene Therapies
Chief Medical Officer
2018-08-01

mark-altmeyer_image

Mark Altmeyer
Mark Altmeyer President & Chief Commercial Officer @ Sio Gene Therapies
President & Chief Commercial Officer
2015-01-01

pavan-cheruvu_image

Pavan Cheruvu
Pavan Cheruvu Chief Executive Officer @ Sio Gene Therapies
Chief Executive Officer
2018-02-01

Founder

vivek-ramaswamy_image

Vivek Ramaswamy

Stock Details

Company's stock symbol is NASDAQ:AXGT

Investors List

herculescapital_image

Hercules Capital

Hercules Capital investment in Post-IPO Debt - Sio Gene Therapies

Official Site Inspections

http://www.siogtx.com Semrush global rank: 8.57 M Semrush visits lastest month: 286

Host Informations
Whois Informations

Loading ...

More informations about "Sio Gene Therapies" on Search Engine